Last reviewed · How we verify
NCT05570877: CHITOCHRONIC
ChitoCare Medical Wound Healing Gel PMCF Study on Healing of Chronic Wounds
NA trial testing ChitoCare medical Wound Healing Gel in Diabetic Foot Ulcer in 92 participants. Completed in 15 October 2024.
15 October 2024
Quick facts
| Lead sponsor | Primex ehf |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 92 |
| Start date | 11 January 2022 |
| Primary completion | 15 October 2024 |
| Estimated completion | 15 October 2024 |
| Sites | 9 locations across Croatia, Slovenia |
Drugs / interventions tested
- ChitoCare medical Wound Healing Gel
Conditions studied
- Diabetic Foot Ulcer — all drugs for Diabetic Foot Ulcer →
- Venous Leg Ulcer — all drugs for Venous Leg Ulcer →
- Pressure Ulcer — all drugs for Pressure Ulcer →
Sponsor
Primex ehf
Who can join
18 and older, any sex, with Diabetic Foot Ulcer or Venous Leg Ulcer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
We are testing a gel intended for the protection and healing of chronic wounds as a support for standard therapy. The main component of the gel is chitosan, a natural polymer that has the ability to stop bleeding, has a positive effect on wound healing, and has antimicrobial properties.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Innovative Functional Biomaterials as Therapeutic Wound Dressings for Chronic Diabetic Foot Ulcers.
Da Silva J, Leal EC, Carvalho E, Silva EA. · · 2023 · cited 27× · PMID 37373045 · DOI 10.3390/ijms24129900 -
Nanoparticle-based approaches for wound healing: a comprehensive review of nanomaterials enhancing tissue regeneration.
Paul P, Hakkimane SS. · · 2025 · cited 1× · PMID 41204016 · DOI 10.1186/s11671-025-04381-w
Verify or expand the search:
- PubMed search for NCT05570877
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetic Foot Ulcer
Currently open trials in the same condition.
- NCT07161830 — Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers · NA · recruiting
- NCT07396376 — Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers · Phase 1, PHASE2 · recruiting
- NCT07291817 — Intermittent Negative Pressure for Patients With Diabetic Foot Ulcers (INPRESS) Study · NA · recruiting
- NCT07209358 — EDX110 Randomized Control Trial for Treatment of DFUs · NA · recruiting
- NCT06938685 — Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers · NA · recruiting
Other Primex ehf trials
Trials by the same sponsor.
- NCT04178525 — Clinical Trial Evaluating the Safety and Efficacy of the Use of Chitosan Gel in Patients With Chronic Wounds · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05570877 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Primex ehf
- Last refreshed: 19 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05570877.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing